维普中文期刊产品整合服务
27篇 您的检索式:作者名="Flechner S"
    题名 作者 年代 出处 被引量
1The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism 显示文摘Koo S H Flechner L Qi L 2005Nature2005,437,7062:1
2Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes显示文摘Flechner S M Kurian S M Head S R 2004Am J Transplant2004,4,9:1
3Single port transumbilical (E-NOTES) donor nephrec- tomy显示文摘Gill I S Canes D Aron M Haber G P Goldfarb D A Flechner S 2008J Urol2008,180,:1
4The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients 显示文摘Flechner SM Glyda M Cockfield S 2011Am J Transplant2011,11,8:1
5Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity显示文摘FLECHNER S M TKOBASHIGAWA J TKLINTMALM G 2008Clin Transplant2008,22,1:1
6Calcineurin inhibitoisparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity 显示文摘Flechner S M Kobashigawa J Klintmalm G 2008Clin Transplant2008,22,1:1
7On aggressiveness and violence in adolescence显示文摘Flechner S 2005Inter- national Journal of Psychoanalysis2005,86,:1
8The ORION study :comparison of two sirolimus-based regimens versus tacrolimus andmycophenolate mofetil in renal allograft recipients 显示文摘Flechner SM Glyda M Cockfield S et ai 2011Am JTransplant2011,11,8:1
9Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine 显示文摘FLECHNER S M GOLDFARB D MODLIN C 2002Transplantation2002,74,8:1
10A randomized prospective trial of low-dose OKT3 induc- tion therapy to prevent rejection and minimize side effects in recipients of kidney transplants显示文摘Flechner S M Goldfarb D A Fairchild R 2000Trans- plantation2000,69,11:1
11The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism显示文摘Koo S H Flechner L Qi L 2005Nature2005,437,7062:1
12The ORION study : comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients显示文摘Flechner SM Glyda M Cockfield S 2011Am J Transplant2011,11,8:1
13De novo kidney transplants without use of calcineurin inhibitors preserves renal structure and function at two year显示文摘Flechner S M Kurian S M Solez K 2004Am J Transplant2004,4,1:1
14The ORION study: comparison of two sirolimus - based regimens versus tacrolimus and mycopbenolate mofetil in renal allograft recipients 显示文摘FLECHNER SM GLYDA M COCKFIELD S et d 2011Am J Transplant2011,11,8:1
15Single-port transumbilical (E- NOTES) donor nephrectomy显示文摘Gill I S Canes D Aron M Haber G P Goldfarb D A Flechner S 2008J Urol2008,180,:1
16The ORION study: comparison of two sirolimus based regimens versus taerolimus and mycophenolate mofetil in renal allograft trcipients 显示文摘Flechner SM Glyda M Cockfield S 2011Am J Transplant2011,11,:1
17The CREB co- activator TORC2 is a key regulator of fasting glucose metabolism显示文摘KOO S H FLECHNER L QI L 2005Nature2005,437,:1
18Kidney transplantion without calcineurin inhibitor drugs:a prospective randomized trail of sirolimus versus cyclosporine显示文摘Flechner S M Goldfarb D Modlin C 2002Transplant2002,74,8:1
19Single port transumbilical (E-NOTES) donor nephrectomy显示文摘Gill I S Canes D Aron M Haber G P Goldfarb D A Flechner S 2008J Urol2008,180,:1
20The ORIONS tudy:comparison of two sirolimus-based regimens versus tacrolimus andmycophenolate mofetil in renal allograft recipients显示文摘Flechner S M Glyda M Cockfield S 2011Am J Trans-plant2011,11,16:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费